514 related articles for article (PubMed ID: 8619099)
1. Investigational agents for rheumatoid arthritis.
Merkel PA; Letourneau EN; Polisson RP
Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
[TBL] [Abstract][Full Text] [Related]
2. Vitaxin applied molecular evolution.
Mikecz K
Curr Opin Investig Drugs; 2000 Oct; 1(2):199-203. PubMed ID: 11249574
[TBL] [Abstract][Full Text] [Related]
3. Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al.
Parker CT; Rennie T
Arthritis Rheum; 2004 Sep; 50(9):3051; author reply 3051-2. PubMed ID: 15457479
[No Abstract] [Full Text] [Related]
4. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
[TBL] [Abstract][Full Text] [Related]
5. [New biological therapeutic options for the treatment of RE: inhibition of costimulatory molecules and blockade of Interleukin-6-interaction].
Perniok A; Rubbert-Roth A
Z Rheumatol; 2003 Oct; 62(5):433-8. PubMed ID: 14579030
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
Kitahara K; Kawai S
Curr Opin Rheumatol; 2007 May; 19(3):238-45. PubMed ID: 17414949
[TBL] [Abstract][Full Text] [Related]
7. Psoriatic arthritis - treatment update.
Mease PJ
Bull NYU Hosp Jt Dis; 2011; 69(3):243-9. PubMed ID: 22035437
[No Abstract] [Full Text] [Related]
8. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
Choy E
Cytokine; 2004 Nov 21-Dec 7; 28(4-5):158-61. PubMed ID: 15588689
[TBL] [Abstract][Full Text] [Related]
10. The new era in the treatment of rheumatoid arthritis.
Putterman C
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):2-4. PubMed ID: 17694188
[No Abstract] [Full Text] [Related]
11. [Treatment of rheumatoid arthritis].
Babić-Naglić D
Reumatizam; 2003; 50(2):22-7. PubMed ID: 15098369
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
13. [Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].
Manger B;
Z Rheumatol; 2002 Dec; 61(6):694-7. PubMed ID: 12491133
[No Abstract] [Full Text] [Related]
14. Rheumatoid arthritis.
Emery P; Foster W; Suarez-Almazor M
Clin Evid; 2002 Jun; (7):1101-21. PubMed ID: 12230730
[No Abstract] [Full Text] [Related]
15. Review of medications used in juvenile rheumatoid arthritis.
Guthrie B; Rouster-Stevens KA; Reynolds SL
Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
[TBL] [Abstract][Full Text] [Related]
16. Leflunomide.
Cannon GW; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
[TBL] [Abstract][Full Text] [Related]
17. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
Krüger K
MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
[No Abstract] [Full Text] [Related]
18. Add-on or step-up trials for new drug development in rheumatoid arthritis: a new standard?
Boers M
Arthritis Rheum; 2003 Jun; 48(6):1481-3. PubMed ID: 12794813
[No Abstract] [Full Text] [Related]
19. Early intervention in rheumatoid arthritis.
Vasanth LC; Paget SA
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189
[No Abstract] [Full Text] [Related]
20. Biological therapies for rheumatoid arthritis: progress to date.
Malviya G; Salemi S; Laganà B; Diamanti AP; D'Amelio R; Signore A
BioDrugs; 2013 Aug; 27(4):329-45. PubMed ID: 23558378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
